Tirzepatide
GLP-1/GIP Dual Agonist
Lyophilized powder — reconstitution with bacteriostatic water or a suitable solvent is required prior to use. BAC Water is available separately in our Solvents category.
Tirzepatide is a dual GIP/GLP-1 receptor co-agonist studied for its effects on glycaemic control, insulin secretion3, and body weight regulation1. Research has explored its superior metabolic efficacy compared to standalone GLP-1 agonists2, with effects on pancreatic beta-cell function, appetite suppression1, and adipose tissue metabolism.
Mechanism of Action
Simultaneously activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, providing additive effects on insulin secretion, glucagon suppression, and satiety signalling.
Third-Party Verified
Certificates of Analysis
Every batch independently tested. COAs are published per lot.